Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > update on stats in relation to FDA advisory panel

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Oct 21, 2023 12:12pm

204 Views

Post# 35694524

RE:RE:RE:update on stats in relation to FDA advisory panel

I don't think they ever published 18m data. But as far as we know everyone who was continuously CR from 90 to 360 stayed CR thereafter.

This would be an easy PR news release BTW. RDW could "congratulate" all the CR patients for continuing to be cancer free after the 450 time point :)

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments